The appropriate angle may also depend on needle length and device design
KLLA: Jens Juul Holst, professor vid Institutionen fr biomedicinsk vetenskap vid Kpenhamns universitet och forskare vid Novo Nordisk Foundation Centre for Basic Metabolism Research
CL: Formal analysis, Investigation, Resources, Writing original draft, Data curation, Methodology, Software
Its January launch gave Novo a three-month head start on capturing customers before Lilly launched its competing Foundayo pill in April
More research is needed to understand the complex relationship between sex and discontinuation reasons
Medications Semaglutide, known by the brand name Wegovy, and liraglutide (Saxenda) have been specifically approved for weight loss in obesity, in combination with lifestyle changes